Correlation Between BioLineRx and Pluri
Can any of the company-specific risk be diversified away by investing in both BioLineRx and Pluri at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioLineRx and Pluri into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioLineRx and Pluri Inc, you can compare the effects of market volatilities on BioLineRx and Pluri and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioLineRx with a short position of Pluri. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioLineRx and Pluri.
Diversification Opportunities for BioLineRx and Pluri
Very weak diversification
The 3 months correlation between BioLineRx and Pluri is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding BioLineRx and Pluri Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pluri Inc and BioLineRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioLineRx are associated (or correlated) with Pluri. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pluri Inc has no effect on the direction of BioLineRx i.e., BioLineRx and Pluri go up and down completely randomly.
Pair Corralation between BioLineRx and Pluri
Given the investment horizon of 90 days BioLineRx is expected to under-perform the Pluri. In addition to that, BioLineRx is 1.49 times more volatile than Pluri Inc. It trades about -0.11 of its total potential returns per unit of risk. Pluri Inc is currently generating about 0.0 per unit of volatility. If you would invest 576.00 in Pluri Inc on November 3, 2024 and sell it today you would lose (140.00) from holding Pluri Inc or give up 24.31% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 99.6% |
| Values | Daily Returns |
BioLineRx vs. Pluri Inc
Performance |
| Timeline |
| BioLineRx |
| Pluri Inc |
BioLineRx and Pluri Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BioLineRx and Pluri
The main advantage of trading using opposite BioLineRx and Pluri positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioLineRx position performs unexpectedly, Pluri can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pluri will offset losses from the drop in Pluri's long position.| BioLineRx vs. Ardelyx | BioLineRx vs. Lexicon Pharmaceuticals | BioLineRx vs. Seres Therapeutics | BioLineRx vs. Immunitybio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |